TABLE 1.
Outcome groups on initial distortion product otoacoustic emissions screening and recorded risk factors.
| Variable | ‘Passed’ screening test (N = 64) |
Requiring repeat DPOAE (N = 57) |
Total screened (N = 121) |
p | |||
|---|---|---|---|---|---|---|---|
| n | % | n | % | N | % | ||
| Admitted to NICU | 1 | 1.5 | 1 | 1.7 | 2 | 1.6 | 0.99 |
| Family history of permanent childhood hearing loss | 6 | 9.3 | 4 | 7 | 10 | 8.2 | 0.75 |
| Exposure to ototoxic drugs | 2 | 3.1 | 1 | 1.7 | 3 | 2.4 | 0.99 |
| Hyperbilirubinemia | 0 | 0 | 1 | 1.7 | 1 | 0.8 | 0.47 |
| Congenital infection | 0 | 0 | 1 | 1.7 | 1 | 0.8 | 0.47 |
| HIV exposure positive | 15 | 23 | 14 | 24.5 | 29 | 24 | 0.99 |
HIV, human immunodeficiency virus; NICU, neonatal intensive care unit; DPOE, distortion product otoacoustic emissions.